Uncategorized

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks – Yahoo Finance

  1. Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks  Yahoo Finance
  2. Why Eli Lilly (LLY) Stock Is Declining Today  Yahoo Finance
  3. Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand  CNBC
  4. Eli Lilly’s stock falls as weight-loss drug sales disappoint  MarketWatch
  5. Lilly forecasts weak fourth-quarter sales of weight-loss drug, shares slump  Reuters